Is there a benefit for CYP2C19 genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients?

Future Medicine, Pharmacogenomics, 12(22), p. 727-730, 2021

Journal article published in 2021 by Wout Wa van den Broek

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by